SPONSOR
Exelixis
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)Solid TumorHepatocellular Carcinoma (HCC)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Head and Neck Squamous Cell Carcinoma (HNSCC)Clear Cell Renal Cell Carcinoma (ccRCC)Non-Clear Cell Renal Cell Carcinoma (nccRCC)
Exelixis is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Exelixis
How many clinical trials has Exelixis sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Exelixis, of which 3 are actively recruiting participants. These trials cover conditions including Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Exelixis research focus on?
Exelixis clinical trials span Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Exelixis clinical trial?
To participate in a Exelixis trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Exelixis trials with current recruitment status updated daily.
Clinical Trials by Exelixis
NCT05176483 Phase 1
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Renal Cell Carcinoma (RCC)
NCT06952010 Phase 1
Recruiting
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Solid Tumor
NCT06545331 Phase 1
Recruiting
Study of XB010 in Subjects With Solid Tumors
Locally Advanced or Metastatic Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology